Banu Bayraktar

628 total citations
42 papers, 428 citations indexed

About

Banu Bayraktar is a scholar working on Epidemiology, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, Banu Bayraktar has authored 42 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 15 papers in Clinical Biochemistry and 12 papers in Infectious Diseases. Recurrent topics in Banu Bayraktar's work include Bacterial Identification and Susceptibility Testing (15 papers), Streptococcal Infections and Treatments (11 papers) and Antibiotic Resistance in Bacteria (10 papers). Banu Bayraktar is often cited by papers focused on Bacterial Identification and Susceptibility Testing (15 papers), Streptococcal Infections and Treatments (11 papers) and Antibiotic Resistance in Bacteria (10 papers). Banu Bayraktar collaborates with scholars based in Türkiye, Antigua and Barbuda and United States. Banu Bayraktar's co-authors include Nazan Dalgıç, Mesut Sancar, Dilek Yıldız Sevgi, Elif Aktaş, Barış Otlu, Ahsen Öncül, İlyas Dökmetaş, Alper Gündüz, Nicolas Fortineau and Çetin Karaca and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Journal of Medical Virology.

In The Last Decade

Banu Bayraktar

37 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Banu Bayraktar Türkiye 14 156 135 127 78 63 42 428
Alistair Leanord United Kingdom 14 170 1.1× 111 0.8× 199 1.6× 91 1.2× 52 0.8× 28 518
Archana Angrup India 13 155 1.0× 156 1.2× 68 0.5× 86 1.1× 82 1.3× 92 486
Kazuhisa Mezaki Japan 11 111 0.7× 112 0.8× 153 1.2× 110 1.4× 37 0.6× 42 378
Toshiki Kajihara Japan 13 139 0.9× 127 0.9× 127 1.0× 89 1.1× 30 0.5× 34 454
Anne Kjerulf Denmark 11 149 1.0× 104 0.8× 99 0.8× 104 1.3× 25 0.4× 24 360
Alexander Mischnik Germany 14 213 1.4× 165 1.2× 166 1.3× 193 2.5× 57 0.9× 34 515
Yoko Takayama Japan 9 107 0.7× 100 0.7× 128 1.0× 49 0.6× 62 1.0× 42 348
Giovanni Gesu Italy 15 213 1.4× 201 1.5× 70 0.6× 94 1.2× 79 1.3× 33 576
Assaf Mizrahi France 16 228 1.5× 277 2.1× 141 1.1× 125 1.6× 54 0.9× 48 591
Bengül Durmaz Türkiye 14 166 1.1× 142 1.1× 92 0.7× 65 0.8× 51 0.8× 42 480

Countries citing papers authored by Banu Bayraktar

Since Specialization
Citations

This map shows the geographic impact of Banu Bayraktar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Banu Bayraktar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Banu Bayraktar more than expected).

Fields of papers citing papers by Banu Bayraktar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Banu Bayraktar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Banu Bayraktar. The network helps show where Banu Bayraktar may publish in the future.

Co-authorship network of co-authors of Banu Bayraktar

This figure shows the co-authorship network connecting the top 25 collaborators of Banu Bayraktar. A scholar is included among the top collaborators of Banu Bayraktar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Banu Bayraktar. Banu Bayraktar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Dalgıç, Nazan, et al.. (2021). An Outbreak of Herbaspirillum Genus Bacteria Bloodstream Infections in Immunocompetent Pediatric Patients. Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection. 15(3). 146–151.
5.
Öncül, Ahsen, Dilek Yıldız Sevgi, Emine Çelik, et al.. (2020). Could we predict the prognosis of the COVID‐19 disease?. Journal of Medical Virology. 93(4). 2420–2430. 21 indexed citations
6.
Aktaş, Elif, et al.. (2019). Is It a Necessity to Use Double Swab in the Detection of Group A Streptococci by the Strep A Rapid Antigen Test?. Türk Mikrobiyoloji Cemiyeti Dergisi. 1 indexed citations
7.
Bayraktar, Banu, et al.. (2018). Comparison of Carba NP-Direct, Carbapenem Inactivation Method, and β-CARBA Tests for Detection of Carbapenemase Production in Enterobacteriaceae. Microbial Drug Resistance. 25(1). 97–102. 17 indexed citations
8.
Dalgıç, Nazan, et al.. (2018). Plasmodium vivax’ın Etken Olduğu Pediatrik Sıtma Olgusu. Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection. 12(1). 33–36. 1 indexed citations
9.
Bayraktar, Banu. (2018). Antibiotic Resistance Trends Of Extended Spectrum Beta Lactamase Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Infections Over the Years. SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital. 53(1). 70–75. 11 indexed citations
10.
Öncül, Ahsen, et al.. (2017). Yoğun Bakım Ünitelerinde Yatan Hastalara Ait Klinik İzolatların Tür Dağılımı ve Antibiyotik Duyarlılıkları. SHILAP Revista de lepidopterología. 15(1). 21–27. 17 indexed citations
11.
Aktaş, Elif, et al.. (2016). VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey. Microbial Drug Resistance. 23(3). 328–334. 35 indexed citations
12.
Sevgi, Dilek Yıldız, et al.. (2015). Serum soluble urokinase-type plasminogen activator receptor and interferon-γ-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B. Wiener klinische Wochenschrift. 128(1-2). 28–33. 19 indexed citations
13.
Topkaya, Aynur Eren, Faruk Aydın, Gülşen Hasçelik, et al.. (2014). Türkiye’de İnvazif Streptokok Enfeksiyonlarının Epidemiyolojisi, Klinik ve Mikrobiyolojik Özellikleri, 2010-2011. Mikrobiyoloji Bulteni. 48(1). 1–13. 3 indexed citations
14.
Karaca, Çetin, et al.. (2012). Serum complement C4 in chronic hepatitis C: Correlation with histopathologic findings and disease activity. The Turkish Journal of Gastroenterology. 23(1). 33–37. 7 indexed citations
15.
Dalgıç, Nazan, et al.. (2011). Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children. Scandinavian Journal of Infectious Diseases. 43(5). 339–343. 26 indexed citations
16.
Dalgıç, Nazan, et al.. (2011). Probiotic, zinc and lactose‐free formula in children with rotavirus diarrhea: Are they effective?. Pediatrics International. 53(5). 677–682. 49 indexed citations
17.
Bayraktar, Banu, et al.. (2010). Klinik örneklerden izole edilen Streptococcus pneumoniae suşlarının çeşitli antibiyotiklere duyarlılıkları. ANKEM Dergisi. 24(1). 7–11. 1 indexed citations
18.
Bayraktar, Banu, et al.. (2010). [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria].. PubMed. 44(2). 187–96. 4 indexed citations
19.
Bayraktar, Banu, et al.. (2007). Yoğun bakım ünitesi hastalarından mini-bal kültürü ile izole edilen ventilatörle ilişkili pnömoni etkenleri ve çeşitli antibiyotiklere duyarlılıkları. Türk Mikrobiyoloji Cemiyeti Dergisi. 37(1). 15–18.
20.
Bayraktar, Banu, et al.. (2004). Yatan ve ayaktan hastalardan izole edilen üriner sistem infeksiyonu etkeni gram negatif çomaklarda antibiyotiklere direnç. ANKEM Dergisi. 18(3). 137–140. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026